UAS
IDXX icon

United Asset Strategies’s Idexx Laboratories IDXX Stock Holding History

United Asset Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,400
Closed -$1.3M – 233
2024
Q1 		$1.3M Sell
2,400
-21,252
-90% -$11.6M 0.13% 130
2023
Q4 		$13.1M Buy
23,652
+444
+2% +$208K 1.47% 19
2023
Q3 		$10.1M Sell
23,208
-311
-1% -$155K 1.31% 22
2023
Q2 		$11.8M Buy
23,519
+277
+1% +$133K 1.47% 18
2023
Q1 		$11.6M Sell
23,242
-497
-2% -$238K 1.53% 19
2022
Q4 		$9.68M Sell
23,739
-58
-0.2% -$22.5K 1.35% 21
2022
Q3 		$7.75M Buy
23,797
+10,330
+77% +$3.79M 1.19% 30
2022
Q2 		$4.72M Buy
+13,467
New +$5.49M 0.69% 45

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

United Asset Strategies's IDXX Position: Q2 2024 in Review

United Asset Strategies sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 2,400 shares — an estimated $1.3M sold.

United Asset Strategies first reported a position in IDXX in Q2 2022 and held it in 8 quarters. The position peaked at $13.1M in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • United Asset Strategies reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • United Asset Strategies sold 2,400 Idexx Laboratories shares in Q2 2024, an estimated $1.3M.
  • United Asset Strategies first reported a position in Idexx Laboratories in Q2 2022 and held it in 8 quarters.
  • United Asset Strategies's Idexx Laboratories position peaked at $13.1M in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on United Asset Strategies's 13F filing for Q2 2024, filed 1 Aug 2024.